Table 2. Demographic Detail of Cases from the Stanley Foundation Array Cohort Used in this Study.
| Control group (n=35) | Bipolar disorder group (n=34) | Schizophrenia group (n=35) | |
|---|---|---|---|
| Age (years) | 44.2 (31–60) | 45.4 (19–64) | 42.6 (19–59) |
| Gender (F, M) | 9, 26 | 18, 16 | 9, 26 |
| Hemisphere (R, L) | 19, 16 | 15, 19 | 18, 17 |
| PH | 6.61 +/− 0.27 | 6.43 +/− 0.30 | 6.48 +/− 0.24 |
| PMI (h) | 29.4 +/− 12.9 | 37.9 +/− 18.6 | 31.4 +/− 15.5 |
| Manner of death | Natural=35 | Natural=19, suicide=15 | Natural=28, suicide=7 |
| Age of onset (years) | — | 25.3±9.2 | 21.3±6.1 |
| Duration of illness (years) | — | 20.2±9.6 | 21.3±10.2 |
| Lifetime antipsychotics (fluphenazine equivalents, mg) | — | 10 212±22 871 | 85 004±10 0335 |
| Antidepressant use | Yes=0, No=35 | Yes=19, No=15 | Yes=9, No=26 |
Abbreviations: F, female; L, left; M, male; R, right.
Data quoted are mean (range)±SD.